Legal framework for CBD in France remains complex

Cannabidiol (CBD), a compound derived from the cannabis plant, is legally sold in France, but it operates within a fragmented regulatory system. Each error in compliance can shift from a minor administrative issue to a criminal offense, creating significant risks for sellers and manufacturers.

Challenges in defining legal CBD products

The main challenge lies in the fact that while CBD itself is not classified as a narcotic, the product containing it is still considered cannabis under French law. This means sellers are judged not just on the CBD molecule but on the entire product, including the plant's origin, THC content, product category, and the commercial messaging used to promote it.

Strict requirements for legal CBD sales

To avoid being classified as a narcotic, CBD products must meet several conditions. They must come from a specific variety of Cannabis sativa L. listed in European or French catalogs, have a THC content below 0.3% in both the plant and finished product, and be cultivated by an active farmer. Proving these conditions is often difficult, and any documentation gaps can lead to legal action.

CBD as medicine and legal risks

A CBD product can be classified as a medicine if it is presented as having curative or preventive properties for human diseases. This classification requires a marketing authorization, which most CBD products lack. Selling such products outside pharmacies is illegal and can lead to prison time and fines.

Regulatory differences across CBD product categories

There is no single "CBD regulation" in France. Instead, CBD products must comply with separate regulations depending on their category—food, cosmetics, vaping products, or smokable flowers. This creates a complex and often confusing compliance landscape for businesses.

CBD in food: a growing legal concern

CBD extracts are classified as new foods under EU regulations, but no authorization has been issued for their sale. Starting in mid-May 2026, a strict control plan was implemented, removing CBD-infused foods from the market without a grace period. This has led to increased scrutiny and legal risks for sellers.

CBD in cosmetics: safety and compliance

CBD is allowed in cosmetics under certain conditions, including the origin of the extract and the safety evaluation of the product. While some safety thresholds have been proposed, they have not yet been formally adopted. Until then, manufacturers must prove the safety of their products independently.

CBD in vaping and smokable products

E-liquids and smokable CBD products are subject to specific regulations, including restrictions on marketing and presentation. These products must be declared in advance and cannot encourage consumption by combustion. New synthetic cannabinoids, such as HHC, are classified as narcotics, adding to the complexity.

Legal risks of marketing and sales practices

The way CBD products are marketed can lead to legal consequences. Using cannabis-related imagery, terms associated with illicit use, or making unverified claims can be seen as incitement to drug use or misleading advertising, both of which carry significant penalties.

Future legal changes and risks

A proposed law aims to prohibit the sale of CBD products to minors and restrict the use of automated dispensers near schools and other public spaces. While this law is not yet in effect, it signals a potential shift in how CBD products are regulated in France. Businesses are advised to prepare for these changes to avoid legal risks.